Schalm S.W.Weiland O.Hansen B.E.Milella M.Lai M.Y.Hollander A.Michielsen P.P.Bellobuono A.Chemello L.Pastore G.DING-SHINN CHENBrouwer J.T.Braconnier J.H.Fryden A.Norkrans G.Reichard O.Adler M.Chamuleau R.A.F.M.Delwaide J.Elewaut A.Fevery J.Hautekeete M.L.Nevens F.Den Ouden-Muller J.W.Wismans P.J.Casalino C.Maselli R.Pietromatera G.Chan K.W.JIA-HORNG KAOIdeo G.Alberti A.Cavalletto L.Boot J.Van Vliet C.2021-09-042021-09-0419990016-5085https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032801727&doi=10.1053%2fgast.1999.0029900408&partnerID=40&md5=d8cba12931392943c9e2d1f07b4cafb7https://scholars.lib.ntu.edu.tw/handle/123456789/582293[SDGs]SDG3Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trialsjournal article10.1053/gast.1999.0029900408104199232-s2.0-0032801727